Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.

@article{Jensen1995IntroductionOA,
  title={Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.},
  author={Klaus M\oller-Ernst Jensen and Peer Carsten Tfelt-Hansen and Erik Wind Hansen and E H Kr\ois and O. Storgaard Pedersen},
  journal={Cephalalgia : an international journal of headache},
  year={1995},
  volume={15 5},
  pages={423-9}
}
A novel self-injector for the administration of subcutaneous sumatriptan in the treatment of migraine attacks was tested in 138 patients recruited by family physicians in Denmark: 108 patients completed the initial double-blind, crossover part of the study. Sumatriptan 6 mg s.c. was significantly better than placebo at 30, 60, 90 and 120 min after injection… CONTINUE READING